Filed with the SEC on · accession 0001213900-26-117201
ADIL filed a 8-K (current report) with the SEC on Nov 9, 2026. Azora Therapeutics (formerly Adial Pharmaceuticals) appointed three new independent directors—Aida Habtezion, Paul Hastings, and Thomas Soloway—to its board and reconstituted its committees, while four existing directors (J.
Azora Therapeutics (formerly Adial Pharmaceuticals) appointed three new independent directors—Aida Habtezion, Paul Hastings, and Thomas Soloway—to its board and reconstituted its committees, while four existing directors (J. Kermit Anderson, Cary J. Claiborne, Robertson H. Gilliland, and Kevin Schuyler) resigned effective the same day.
✦ Ask GOAX AI about this filing — what it means for ADIL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ADIL?
Click hereADIL filed a 8-K (Board change). Azora Therapeutics (formerly Adial Pharmaceuticals) appointed three new independent directors—Aida Habtezion, Paul Hastings, and Thomas Soloway—to its board and reconstituted its committees, while four existing directors (J. Kermit Anderson, Cary J. Claiborne, Robertson H. Gilliland, and Kevin Schuyler) resigned effective the same day.
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Get alerts when ADIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days